PURPOSE: To describe the methods for family and case-control recruitment for a multicenter genetic and associated heritability analyses of Fuchs endothelial corneal dystrophy (FECD). METHODS: Twenty-nine enrolling sites with 62 trained investigators and coordinators gathered individual and family information, graded the phenotype, and collected blood and/or saliva for genetic analysis on all individuals with and without FECD. The degree of FECD was assessed in a 0 to 6 semiquantitative scale using standardized clinical methods with pathological verification of FECD on at least 1 member of each family. Central corneal thickness was measured by ultrasonic pachymetry. RESULTS: Three hundred twenty-two families with 330 affected sibling pairs with FECD were enrolled and included a total of 650 sibling pairs of all disease grades. Using the entire 7-step FECD grading scale or a dichotomous definition of severe disease, heritability was assessed in families via sib-sib correlations. Both binary indicators of severe disease and semiquantitative measures of disease severity were significantly heritable, with heritability estimates of 30% for severe disease, 37% to 39% for FECD score, and 47% for central corneal thickness. CONCLUSIONS: Genetic risk factors have a strong role in the severity of the FECD phenotype and corneal thickness. Genotyping this cohort with high-density genetic markers followed by appropriate statistical analyses should lead to novel loci for disease susceptibility.
PURPOSE: To describe the methods for family and case-control recruitment for a multicenter genetic and associated heritability analyses of Fuchs endothelial corneal dystrophy (FECD). METHODS: Twenty-nine enrolling sites with 62 trained investigators and coordinators gathered individual and family information, graded the phenotype, and collected blood and/or saliva for genetic analysis on all individuals with and without FECD. The degree of FECD was assessed in a 0 to 6 semiquantitative scale using standardized clinical methods with pathological verification of FECD on at least 1 member of each family. Central corneal thickness was measured by ultrasonic pachymetry. RESULTS: Three hundred twenty-two families with 330 affected sibling pairs with FECD were enrolled and included a total of 650 sibling pairs of all disease grades. Using the entire 7-step FECD grading scale or a dichotomous definition of severe disease, heritability was assessed in families via sib-sib correlations. Both binary indicators of severe disease and semiquantitative measures of disease severity were significantly heritable, with heritability estimates of 30% for severe disease, 37% to 39% for FECD score, and 47% for central corneal thickness. CONCLUSIONS: Genetic risk factors have a strong role in the severity of the FECD phenotype and corneal thickness. Genotyping this cohort with high-density genetic markers followed by appropriate statistical analyses should lead to novel loci for disease susceptibility.
Authors: Danielle N Meadows; Allen O Eghrari; S Amer Riazuddin; David G Emmert; Nicholas Katsanis; John D Gottsch Journal: Invest Ophthalmol Vis Sci Date: 2009-07-15 Impact factor: 4.799
Authors: John D Gottsch; Olof H Sundin; Erik V Rencs; David G Emmert; Walter J Stark; Clement J Cheng; Gregory W Schmidt Journal: Cornea Date: 2006-05 Impact factor: 2.651
Authors: S Amer Riazuddin; Allen O Eghrari; Amr Al-Saif; Lisa Davey; Danielle N Meadows; Nicholas Katsanis; John D Gottsch Journal: Invest Ophthalmol Vis Sci Date: 2009-07-15 Impact factor: 4.799
Authors: Eranga N Vithana; Patricio E Morgan; Vedam Ramprasad; Donald T H Tan; Victor H K Yong; Divya Venkataraman; Anandalakshmi Venkatraman; Gary H F Yam; Soumittra Nagasamy; Ricky W K Law; Rama Rajagopal; Chi P Pang; Govindsamy Kumaramanickevel; Joseph R Casey; Tin Aung Journal: Hum Mol Genet Date: 2007-11-16 Impact factor: 6.150
Authors: John A Landers; Alex W Hewitt; David P Dimasi; Jac C Charlesworth; Tania Straga; Richard A D Mills; Ravi Savarirayan; David A Mackey; Kathryn P Burdon; Jamie E Craig Journal: Invest Ophthalmol Vis Sci Date: 2009-05-06 Impact factor: 4.799
Authors: Natalie A Afshari; Yi-Ju Li; Margaret A Pericak-Vance; Simon Gregory; Gordon K Klintworth Journal: Invest Ophthalmol Vis Sci Date: 2008-05-23 Impact factor: 4.799
Authors: S Amer Riazuddin; Norann A Zaghloul; Amr Al-Saif; Lisa Davey; Bill H Diplas; Danielle N Meadows; Allen O Eghrari; Mollie A Minear; Yi-Ju Li; Gordon K Klintworth; Natalie Afshari; Simon G Gregory; John D Gottsch; Nicholas Katsanis Journal: Am J Hum Genet Date: 2009-12-31 Impact factor: 11.025
Authors: Mehul Nagarsheth; Annapurna Singh; Brian Schmotzer; Denise C Babineau; Joel Sugar; W Barry Lee; Sudha K Iyengar; Jonathan H Lass Journal: Arch Ophthalmol Date: 2012-11
Authors: Xiaolin Zhang; Robert P Igo; Jeremy Fondran; V Vinod Mootha; Matt Oliva; Kristin Hammersmith; Alan Sugar; Jonathan H Lass; Sudha K Iyengar Journal: Invest Ophthalmol Vis Sci Date: 2013-08-27 Impact factor: 4.799
Authors: Laura J Kopplin; Katie Przepyszny; Brian Schmotzer; Karen Rudo; Denise C Babineau; Sanjay V Patel; David D Verdier; Ula Jurkunas; Sudha K Iyengar; Jonathan H Lass Journal: Arch Ophthalmol Date: 2012-04
Authors: Stephan Ong Tone; Matthew James Bruha; Myriam Böhm; Christina Prescott; Ula Jurkunas Journal: Can J Ophthalmol Date: 2019-06-17 Impact factor: 1.882
Authors: Ching-Yu Cheng; Maria Schache; M Kamran Ikram; Terri L Young; Jeremy A Guggenheim; Veronique Vitart; Stuart MacGregor; Virginie J M Verhoeven; Veluchamy A Barathi; Jiemin Liao; Pirro G Hysi; Joan E Bailey-Wilson; Beate St Pourcain; John P Kemp; George McMahon; Nicholas J Timpson; David M Evans; Grant W Montgomery; Aniket Mishra; Ya Xing Wang; Jie Jin Wang; Elena Rochtchina; Ozren Polasek; Alan F Wright; Najaf Amin; Elisabeth M van Leeuwen; James F Wilson; Craig E Pennell; Cornelia M van Duijn; Paulus T V M de Jong; Johannes R Vingerling; Xin Zhou; Peng Chen; Ruoying Li; Wan-Ting Tay; Yingfeng Zheng; Merwyn Chew; Kathryn P Burdon; Jamie E Craig; Sudha K Iyengar; Robert P Igo; Jonathan H Lass; Emily Y Chew; Toomas Haller; Evelin Mihailov; Andres Metspalu; Juho Wedenoja; Claire L Simpson; Robert Wojciechowski; René Höhn; Alireza Mirshahi; Tanja Zeller; Norbert Pfeiffer; Karl J Lackner; Thomas Bettecken; Thomas Meitinger; Konrad Oexle; Mario Pirastu; Laura Portas; Abhishek Nag; Katie M Williams; Ekaterina Yonova-Doing; Ronald Klein; Barbara E Klein; S Mohsen Hosseini; Andrew D Paterson; Kari-Matti Makela; Terho Lehtimaki; Mika Kahonen; Olli Raitakari; Nagahisa Yoshimura; Fumihiko Matsuda; Li Jia Chen; Chi Pui Pang; Shea Ping Yip; Maurice K H Yap; Akira Meguro; Nobuhisa Mizuki; Hidetoshi Inoko; Paul J Foster; Jing Hua Zhao; Eranga Vithana; E-Shyong Tai; Qiao Fan; Liang Xu; Harry Campbell; Brian Fleck; Igor Rudan; Tin Aung; Albert Hofman; André G Uitterlinden; Goran Bencic; Chiea-Chuen Khor; Hannah Forward; Olavi Pärssinen; Paul Mitchell; Fernando Rivadeneira; Alex W Hewitt; Cathy Williams; Ben A Oostra; Yik-Ying Teo; Christopher J Hammond; Dwight Stambolian; David A Mackey; Caroline C W Klaver; Tien-Yin Wong; Seang-Mei Saw; Paul N Baird Journal: Am J Hum Genet Date: 2013-08-08 Impact factor: 11.025
Authors: Stephan Ong Tone; Viridiana Kocaba; Myriam Böhm; Adam Wylegala; Tomas L White; Ula V Jurkunas Journal: Prog Retin Eye Res Date: 2020-05-08 Impact factor: 21.198